Pfizer to merge off-patent business with Mylan

30 July 2019 - Deborah Wilkes

Premium

Pfizer has announced plans to merge its off-patent pharmaceutical business Upjohn with generics company Mylan. The deal includes Mylan's OTC products with sales in excess of USD1 billion.

Click tags below for more information on topics:

Pfizer

Annual Subscription Holder?

Sign in to continue reading.
 

Sign In

Back to Industry News

Share this page: